Cytosorbents Corp Share Price OTC Bulletin Board
Equities
US23283X2062
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
06-24 | CytoSorbents' Blood Purification Device Gets Approval in Taiwan | MT |
06-24 | CytoSorbents Corporation Announces Regulatory Approval of CytoSorb® in Taiwan | CI |
Sales 2024 * | 39.52M 3.12B | Sales 2025 * | 46.83M 3.7B | Capitalization | 38.18M 3.01B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.58B | Net income 2025 * | -9M -711M | EV / Sales 2024 * | 0.97 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.82 x |
P/E ratio 2024 * |
-1.92
x | P/E ratio 2025 * |
-3.91
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Vincent Capponi
PSD | President | 66 | 24/04/02 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 13/07/15 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Edward Jones
BRD | Director/Board Member | 75 | 31/03/07 |
1st Jan change | Capi. | |
---|---|---|
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+2.70% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B | |
+11.28% | 28.12B |